Crick — Clinical Intelligence Platform

Not applicableLooking for participantsNCT05462574

What this trial is testing

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

Who this might be right for

Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease

Vanderbilt University Medical Center 75

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension

Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension

Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)

Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)

Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension

Observatory of Pulmonary Arterial Hypertension of Congenital Heart Disease

Hemodynamic Changes in Connective Tissue Disease

Cardiac Magnetic Resonance Imaging and Pulmonary Perfusion

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

Bosentan in Treatment of Pulmonary Arterial Hypertension

Patient Reported Outcomes in Pulmonary Arterial Hypertension

Riociguat in Triple Therapy for Pulmonary Arterial Hypertension in Real-World Practice

Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension

Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)

Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

Functional Exercise Tests in Patients With Systemic Sclerosis

AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?

Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring

European Registry of Acutely Decompensated Pulmonary Arterial Hypertension